Dr Agarwal's Eye Hospital Ltd
BSE:526783
Intrinsic Value
Dr. Agarwal's Eye Hospital Ltd. operates as an eye hospital, which engages in the provision of eye care solutions. [ Read More ]
The intrinsic value of one
DRAGARWQ
stock under the Base Case scenario is
1 552.33
INR.
Compared to the current market price of 3 320 INR,
Dr Agarwal's Eye Hospital Ltd
is
Overvalued by 53%.
Dr Agarwal's Eye Hospital Ltd's market capitalization is 15.6B INR.
DRAGARWQ stock price is 3 320 INR.
DRAGARWQ stock (1 552.33 INR) is 53% less than its price (3320 INR).
DRAGARWQ stock (1 091.34 INR) is 67% less than its price (3320 INR). Open DCF Valuation
DRAGARWQ stock (2 013.32 INR) is 39% less than its price (3320 INR). Open Relative Valuation
DRAGARWQ.
DRAGARWQ has positive Net Income for the last twelve months.
DRAGARWQ's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 13%.
DRAGARWQ's Revenue has grown by 19% over the past 12 months.
DRAGARWQ has positive three-year average ROIC (Return on Invested Capital): 14%. The company is efficient at using invested capital to generate operating income.
DRAGARWQ has positive Operating Income for the last twelve months.
DRAGARWQ has positive Free Cash Flow for the last twelve months.
DRAGARWQ's long-term assets (5B INR) exceed its long-term liabilties (3B INR).
DRAGARWQ's D/E (Debt to Equity) is equal to 1.58.
DRAGARWQ's ROIC (Return on Invested Capital) has significantly increased in the last 3 years from -3% to 13%.
DRAGARWQ's ROE (Return on Equity) for the past 12 months is very high and is equal to 34%.
DRAGARWQ's ROE (Return on Equity) has significantly increased in the last 3 years from -3% to 34%.
DRAGARWQ's short-term liabilties (808m INR) exceed its short-term assets (598m INR).
DRAGARWQ's Revenue has been growing by an exceptional 32% per year for the last 3 years.
DRAGARWQ has positive Gross Profit for the last twelve months.
DRAGARWQ has very high three-year average ROE (Return on Equity): 33%. The company is very efficient at transforming stockholders' equity into net income.
DRAGARWQ has positive Net Debt. This means that the company has more debt (2B INR) than cash and short-term investments (357m INR).
DRAGARWQ's Altman Z-Score is very high and is equal to 3.95.
DRAGARWQ earns more than enough operating income (645m INR) to safely cover interest payments on its debt (2m INR).
Valuation Backtest
Dr Agarwal's Eye Hospital Ltd
Run backtest to discover the historical profit from buying and selling
DRAGARWQ
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Dr Agarwal's Eye Hospital Ltd
Balance Sheet Decomposition
Dr Agarwal's Eye Hospital Ltd
| Current Assets | 598.3m |
| Cash & Short-Term Investments | 357m |
| Receivables | 129.3m |
| Other Current Assets | 112m |
| Non-Current Assets | 4.4B |
| PP&E | 4.1B |
| Intangibles | 8m |
| Other Non-Current Assets | 228.6m |
| Current Liabilities | 807.7m |
| Accounts Payable | 318.4m |
| Other Current Liabilities | 489.3m |
| Non-Current Liabilities | 2.6B |
| Long-Term Debt | 2.5B |
| Other Non-Current Liabilities | 97.9m |
Earnings Waterfall
Dr Agarwal's Eye Hospital Ltd
|
Revenue
|
3.2B
INR
|
|
Cost of Revenue
|
-705.5m
INR
|
|
Gross Profit
|
2.5B
INR
|
|
Operating Expenses
|
-1.8B
INR
|
|
Operating Income
|
644.5m
INR
|
|
Other Expenses
|
-180.9m
INR
|
|
Net Income
|
463.6m
INR
|
Free Cash Flow Analysis
Dr Agarwal's Eye Hospital Ltd
DRAGARWQ Profitability Score
Profitability Due Diligence
Dr Agarwal's Eye Hospital Ltd's profitability score is 69/100. The higher the profitability score, the more profitable the company is.
Score
Dr Agarwal's Eye Hospital Ltd's profitability score is 69/100. The higher the profitability score, the more profitable the company is.
DRAGARWQ Solvency Score
Solvency Due Diligence
Dr Agarwal's Eye Hospital Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Score
Dr Agarwal's Eye Hospital Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DRAGARWQ Price Targets Summary
Dr Agarwal's Eye Hospital Ltd
Shareholder Return
DRAGARWQ Price
Dr Agarwal's Eye Hospital Ltd
| Average Annual Return | 57.5% |
| Standard Deviation of Annual Returns | 76.31% |
| Max Drawdown | -47% |
| Market Capitalization | 15.6B INR |
| Shares Outstanding | 4 700 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Dr Agarwal's Eye Hospital Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Dr. Agarwal's Eye Hospital Ltd. operates as an eye hospital, which engages in the provision of eye care solutions. The company is headquartered in Chennai, Tamil Nadu. The firm provides eye anatomy & treatments, including retina, uvea, cornea, orbit, photocoagulation, vitrectomy, anti vegf, dry eyes, scleral buckle, pre descemets endothelial keratoplasty (PDEK), refractive surgery and paediatric ophthalmology. The company also provides treatment for cataract, glaucoma, squint, diabetic retinopathy, retinal detachment, retinopathy prematurity, macular edema, traumatic cataract, macular hole, posterior subcapsular cataract, rosette cataract and congenital glaucoma. The firm provides its services in various locations in India, including Tamil Nadu, Karnataka, Maharashtra, Kerala, West Bengal, Odisha, Andhra Pradesh, Puducherry, Gujarat, Rajasthan, Madhya Pradesh and Andaman.
Contact
IPO
Employees
Officers
The intrinsic value of one
DRAGARWQ
stock under the Base Case scenario is
1 552.33
INR.
Compared to the current market price of 3 320 INR,
Dr Agarwal's Eye Hospital Ltd
is
Overvalued by 53%.
You don't have any saved screeners yet
